RZ-001
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for RZ-001, covering 2024-11-04 to 2025-09-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 With Valganciclovir (VGCV) in Subjects With Glioblastoma [Phase 1, Phase 2]